FindTrial
Sign In

Head-to-Head Comparison of 68Ga-Pentixafor and 18F-FDG PET/CT in Patients with Indolent Small B-Cell Lymphoma: A Prospective, Single-center Observational Study

Head-to-Head Comparison of 68Ga-Pentixafor and 18F-FDG PET/CT in Patients with Indolent Small B-Cell Lymphoma: A Prospective, Single-center Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081464
Enrollment
Unknown
Registered
2024-03-01
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Indolent Small B-Cell Lymphoma

Interventions

Case series:None

Sponsors

Department of Nuclear Medicine, West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Pathological histology confirmed as Indolent Small B-Cell Lymphoma. 2. Patients who did not receive any treatment. 3. Age = 18 years old.

Exclusion criteria

Exclusion criteria: 1.Women during pregnancy or lactation. 2. Concomitant other malignant tumors 3. Patients who could not sign the informed consent form of the scan.

Design outcomes

Primary

MeasureTime frame
receiver operating characteristic curve, ROC;sensitivity;specificity;Youden's index;likelihood ratio, LR;—

Countries

China

Contacts

Public ContactRong Tian

Department of Nuclear Medicine, West China Hospital of Sichuan University

rongtiannuclear@126.com+86 189 8060 1586

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026